Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction

Fetal Diagnosis and Therapy

Volumn 26, Issue 1, 2009, Pages 24-28

  Al Nakib, M ^a   Desbriere R ^a   Bonello, N ^a   Bretelle, F ^a   Boubli, L ^a   Gabert, J ^a   Levy Mozziconacci, A ^a  

^a HÔPITAL NORD   (France)

Author keywords

Cell free DNA; Fetal DNA; Intrauterine growth restriction; Placental insufficiency

Indexed keywords

DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FALSE POSITIVE RESULT; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; MATERNAL AGE; MATERNAL BLOOD; NUCLEOTIDE SEQUENCE; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; CASE-CONTROL STUDIES; DNA; FEMALE; FETAL GROWTH RETARDATION; GENETIC MARKERS; HUMANS; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 70350755608     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236355     Document Type: Article

References (36)

1. Villar J, Carrolli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjo P, Bakketeig L, Lumbiganon P, Campodonico L, Al-Mazrou Y, Lindheimer M, Kramer M; World Health Organization Antenatal Care Trial Research Group: Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006; 194: 921-931.
2. Morrison JJ, Hastings R, Jauniaux E: Trisomy 22: a cause of isolated fetal growth restriction. Ultrasound Obstet Gynecol 1998; 11: 295-297.
3. Goldenberg A, Wolf C, Chevy F, Benachi A, Dumez Y, Munnich A, Cormier-Daire V: Antenatal manifestations of Smith-Lemli- Opitz (RSH) syndrome: a retrospective survey of 30 cases. Am J Med Genet A 2004; 124: 423-426.
4. Ness RB, Sibai BM.: Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40-49.
5. Chavarria ME, Lara-González L, Gonzalez- Gleason A, Sojo I, Reyes A: Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol 2002; 187: 595-601.
6. Conde-Agudelo A, Villar J, Lindheimer M: World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104: 1367-1391.
7. Wald NJ, Morris JK, Ibison J, Wu T, George LM: Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Prenat Diagn 2006; 26: 559-564.
8. Odibo AO, Sehdev HM, Stamilio DM, Macones GA: Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. Am J Perinatol 2006; 23: 363-368.
9. Mylonas I, Schiessl B, Jeschke U, Vogl J, Makrigiannakis A, Kuhn C, Kunze S, Schulze S, Kainer F, Friese K: Expression of inhibin/ activin subunits alpha (-), beta A (-A) and beta B (-B) in placental tissue of normal and intrauterine growth restricted (IUGR) pregnancies. J Mol Histol 2006; 37: 43-52.
10. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW: Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45: 184-188.
11. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, Hahn S: Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001; 184: 414-419.
12. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA: Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002; 48: 650-653.
13. Smid M, Vassallo A, Lagona F, Valsecchi L, Maniscalco L, Danti L, Lojacono A, Ferrari A, Ferrari M, Cremonesi L: Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann NY Acad Sci 2001; 945: 132-137.
14. Zhong XY, Holzgreve W, Hahn S: Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann NY Acad Sci 2001; 945: 138-140.
15. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF, Wataganara T, Romero R, Bianchi DW: Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190: 707-713.
16. Sekizawa A, Farina A., Koide K, Iwasaki M, Honma S, Ichizuka K, Saito H, Okai T: Betaglobin DNA in maternal plasma as a molecular marker of pre-eclampsia. Prenat Diagn 2004; 24: 697-700.
17. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM: Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001; 47: 137-139.
18. Zhong XY, Holzgreve W, Hahn S: The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002; 21: 77-83.
19. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T: Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 2004; 24: 722-726.
20. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
21. Gonzalez-Gonzalez C, Garcia-Hoyos M, Trujillo-Tiebas MJ, Lorda-Sanchez I, de Alba MR, Infantes F, Gallego J, Diaz-Recasens J, Ayuso C, Ramos C: Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience. J Histochem Cytochem 2005; 53: 307-314.
22. Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B: A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome. Prenat Diagn 2006; 26: 831-836.
23. Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah S, Avent ND, Soothill PW: Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol 2009; 200: 98.
24. Caramelli E, Rizzo N, Concu M, Simonazzi G, Carinci P, Bondavalli C, Bovicelli L, Farina A: Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study. Prenat Diagn 2003; 23: 367-371.
25. La Torre R, Nigro G, Mazzocco M, Best AM, Adler SP: Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006; 43: 994-1000.
26. Wright A, Zhou Y, Weier JF, Caceres E, Kapidzic M, Tabata T, Kahn M, Nash C, Fisher SJ: Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am J Med Genet 2004; 130: 354-364.
27. Bischoff FZ, Lewis DE, Simpson JL: Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005; 11: 59-67.
28. Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, Palomaki GE, Bianchi DW: Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem 2003; 49: 239-242.
29. Gupta A, Hasler P, Gebhardt S, Holzgreve W, Hahn S: Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA? Ann NY Acad Sci 2006; 1075: 118-122.
30. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ: Trophoblastic oxydative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006; 169: 400-404.
31. Gupta AK, Holzgreve W, Huppertz B, Malek A, Schneider H, Hahn S: Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem 2004; 50: 2187-2190.
32. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, von Dadelszen P: Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006; 27: 56-61.
33. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ: Does endothelial cell activation occur with intrauterine growth restriction? BJOG 2002; 109: 836-839.
34. Bretelle F, Sabatier F, Blann A, D'Ercole C, Boutiere B, Mutin M, Boubli L, Sampol J, Dignat-George F: Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia. BJOG 2001; 108: 1277-1282.
35. Smith GC, Pell JP, Walsh D: Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357: 2002-2006.
36. Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G: Uterine Doppler velocimetry and placental hypoxicischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999; 20: 389-394.